Concert Pharmaceuticals Inc.

10/25/2021 | Press release | Distributed by Public on 10/25/2021 05:08

Concert Pharmaceuticals Completes Enrollment in THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata